Related references
Note: Only part of the references are listed.Low-dose Btk inhibitors selectively block platelet activation by CLEC-2
Phillip L. R. Nicolson et al.
HAEMATOLOGICA (2021)
Preclinical Efficacy and Anti-Inflammatory Mechanisms of Action of the Bruton Tyrosine Kinase Inhibitor Rilzabrutinib for Immune-Mediated Disease
Claire L. Langrish et al.
JOURNAL OF IMMUNOLOGY (2021)
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Enzymes
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Catalytic receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein-coupled receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Inhibitors targeting Bruton's tyrosine kinase in cancers: drug development advances
Tingyu Wen et al.
LEUKEMIA (2021)
Risk of Infection Associated With Ibrutinib in Patients With B-Cell Malignancies: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Somedeb Ball et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2020)
Inhibition of Bruton's TK regulates macrophage NF-κB and NLRP3 inflammasome activation in metabolic inflammation
Gareth S. D. Purvis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020
Elliott Lilley et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Inhibition of Bruton tyrosine kinase in patients with severe COVID-19
Mark Roschewski et al.
SCIENCE IMMUNOLOGY (2020)
Ibrutinib-Mediated Atrial Fibrillation Attributable to Inhibition of C-Terminal Src Kinase
Ling Xiao et al.
CIRCULATION (2020)
A rationale for blocking thromboinflammation in COVID-19 with Btk inhibitors
Phillip L. R. Nicolson et al.
PLATELETS (2020)
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
Nathalie Percie du Sert et al.
PLOS BIOLOGY (2020)
Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19 A Meta-analysis
Jonathan A. C. Sterne et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Selective inhibition of thromboinflammation in COVID-19 by Btk inhibitors
Wolfgang Siess et al.
PLATELETS (2020)
X-Linked Immunodeficient Mice With No Functional Bruton's Tyrosine Kinase Are Protected From Sepsis-Induced Multiple Organ Failure
Caroline E. O'Riordan et al.
FRONTIERS IN IMMUNOLOGY (2020)
How Have Leukocyte In Vitro Chemotaxis Assays Shaped Our Ideas about Macrophage Migration?
Agata N. Rumianek et al.
BIOLOGY-BASEL (2020)
Chemokines as Therapeutic Targets in Cardiovascular Disease The Road Behind, The Road Ahead
Heidi Noels et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Bruton's Tyrosine Kinase Inhibition Attenuates the Cardiac Dysfunction Caused by Cecal Ligation and Puncture in Mice
Caroline E. O'Riordan et al.
FRONTIERS IN IMMUNOLOGY (2019)
Btk inhibitor ibrutinib reduces inflammatory myeloid cell responses in the lung during murine pneumococcal pneumonia
Alexander P. de Porto et al.
MOLECULAR MEDICINE (2019)
Synovial fluid monocyte/macrophage subsets and their correlation to patient-reported outcomes in osteoarthritic patients: a cohort study
Alejandro Gomez-Aristizabal et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Identification of AnnexinA1 as an Endogenous Regulator of RhoA, and Its Role in the Pathophysiology and Experimental Therapy of Type-2 Diabetes
Gareth S. D. Purvis et al.
FRONTIERS IN IMMUNOLOGY (2019)
Targeting Bruton's tyrosine kinase for the treatment of B cell associated malignancies and autoimmune diseases: Preclinical and clinical developments of small molecule inhibitors
Zhen Zhang et al.
ARCHIV DER PHARMAZIE (2018)
Ibrutinib blocks Btk-dependent NF-κB and NFAT responses in human macrophages during Aspergillus fumigatus phagocytosis
Amelia Bercusson et al.
BLOOD (2018)
Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers
Michael J. Curtis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Metabolic regulation of leukocyte motility and migration
Federica M. Marelli-Berg et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2018)
Activation of the Immune-Metabolic Receptor GPR84 Enhances Inflammation and Phagocytosis in Macrophages
Carlota Recio et al.
FRONTIERS IN IMMUNOLOGY (2018)
Tracking Monocyte Recruitment and Macrophage Accumulation in Atherosclerotic Plaque Progression Using a Novel hCD68GFP/ApoE-/- Reporter Mouse-Brief Report
Eileen McNeill et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
IκB Kinase Inhibitor Attenuates Sepsis-Induced Cardiac Dysfunction in CKD
Jianmin Chen et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Human NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase
Xiao Liu et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Transcriptome profiling of monocytes from XLA patients revealed the innate immune function dysregulation due to the BTK gene expression deficiency
Hoda Mirsafian et al.
SCIENTIFIC REPORTS (2017)
Inhibition of IκB Kinase at 24 Hours After Acute Kidney Injury Improves Recovery of Renal Function and Attenuates Fibrosis
Florence L. Johnson et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Absence of the Non-Signaling Chemerin Receptor CCRL2 Exacerbates Acute Inflammatory Responses In Vivo
Daniel Regan-Komito et al.
FRONTIERS IN IMMUNOLOGY (2017)
Bruton's Tyrosine Kinase: An Emerging Key Player in Innate Immunity
Alexander N. R. Weber et al.
FRONTIERS IN IMMUNOLOGY (2017)
NF-kappa B signaling in inflammation
Ting Liu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2017)
BTK inhibition is a potent approach to block IgE-mediated histamine release in human basophils
D. Smiljkovic et al.
ALLERGY (2017)
Acute exposure to apolipoprotein A1 inhibits macrophage chemotaxis in vitro and monocyte recruitment in vivo
Asif J. Iqbal et al.
ELIFE (2016)
Bruton's tyrosine kinase is essential for NLRP3 inflammasome activation and contributes to ischaemic brain injury
Minako Ito et al.
NATURE COMMUNICATIONS (2015)
Hydrodynamic Gene Delivery of CC Chemokine Binding Fc Fusion Proteins to Target Acute Vascular Inflammation In Vivo
Eileen McNeill et al.
SCIENTIFIC REPORTS (2015)
Btk inhibition suppresses agonist-induced human macrophage activation and inflammatory gene expression in RA synovial tissue explants
Linda M. Hartkamp et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Btk Regulates Macrophage Polarization in Response to Lipopolysaccharide
Joan Ni Gabhann et al.
PLOS ONE (2014)
A Real Time Chemotaxis Assay Unveils Unique Migratory Profiles amongst Different Primary Murine Macrophages
Asif J. Iqbal et al.
PLOS ONE (2013)
CC Chemokine Receptors and Chronic Inflammation-Therapeutic Opportunities and Pharmacological Challenges
Gemma E. White et al.
PHARMACOLOGICAL REVIEWS (2013)
The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting the emigration of macrophages from plaques
Janine M. van Gils et al.
NATURE IMMUNOLOGY (2012)
Specific Btk inhibition suppresses B cell- and myeloid cell-mediated arthritis
Julie A. Di Paolo et al.
NATURE CHEMICAL BIOLOGY (2011)
Overcoming hurdles in developing successful drugs targeting chemokine receptors
Thomas J. Schall et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Tyrosine kinase Btk regulates E-selectin-mediated integrin activation and neutrophil recruitment by controlling phospholipase C (PLC) γ2 and PI3Kγ pathways
Helena Mueller et al.
BLOOD (2010)
A New Strategy for the Identification of Novel Molecules with Targeted Proresolution of Inflammation Properties
Roberta A. Navarro-Xavier et al.
JOURNAL OF IMMUNOLOGY (2010)
The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy
Lee A. Honigberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites
Filip K. Swirski et al.
SCIENCE (2009)
Generation of peripheral B cells occurs via two spatially and temporally distinct pathways
Robert Coleman Lindsley et al.
BLOOD (2007)
Pleiotropic consequences of Bruton tyrosine kinase deficiency in myeloid lineages lead to poor inflammatory responses
A Mangla et al.
BLOOD (2004)
Macrophage effector functions controlled by Bruton's tyrosine kinase are more crucial than the cytokine balance of T cell responses for microfilarial clearance
S Mukhopadhyay et al.
JOURNAL OF IMMUNOLOGY (2002)
Share Paper
